Quest Laboratories Limited IPO
₹93 - ₹97
1200
N/A
| Open Date: | 15-May-2024 |
| Close Date: | 17-May-2024 |
| Allotment Date: | 21-May-2024 |
| Listing Date: | 23-May-2024 |
| Listing Price: | N/A |
| Face Value: | ₹10 Per Equity Share |
| Issue Price: | ₹93-97 Per Equity Share |
| Issue Size: | Total Issue Size 4,449,600 shares (aggregating up to ₹43.16 Cr) : Fresh Issue 4,449,600 shares (aggregating up to ₹43.16 Cr) |
| Market Lot (Min Amount): | Retail - ₹116,400 : HNI - ₹232,800 |
| Earning Per Share(EPS) | ₹4.21/- |
| P/E Ratio | 23.03 |
| RoNW | 34.03% |
| Net Asset Value (NAV) - Post Issue: | ₹13.93/- |
| Total Assets | Total Revenue | Profit After Tax | |
|---|---|---|---|
| 31 Dec,2023 | 5,869.09 | 6,217.83 | 774.93 |
| 31 Mar,2023 | 4,664.72 | 6,186.60 | 502.85 |
| 31 Mar,2022 | 3,479.86 | 5,954.20 | 410.50 |
| 31 Mar,2021 | 1,839.63 | 3,043.55 | 65.50 |
| Pre Issue Share Holding | 90.36% |
| Post Issue Share Holding | 65.82% |
| 1. Mr. Anil Kumar Sabarwal |
| 2. Ms. Tejaswini Sabarwal |
The company proposes to utilize the Net Proceeds from the Issue towards funding the following objects:
- Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility;
- Funding working capital requirements of the company;
- General corporate purposes;
Incorporated in June 1998, Quest Laboratories Limited is a pharmaceutical company manufacturing a range of antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
The company operates in the domestic market across twelve (12) states and two (2) union territories. These include Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar.
The manufacturing unit of the company is located in Dhar, Madhya Pradesh.
The company holds WHO Schedule M GMP and GLP certifications, as well as ISO/IEC 17025:2017 and ISO 9001:2015 certifications.
By December 31st, 2023, the company employs 83 individuals to lookafter various aspects of its manufacturing operations, including production, quality control, technical and engineering support services, inventory management, administration, accounting, and other functions such as storage, packing, and dispatch.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.